a public good project by the
Synthesis
Company
of California

© 2026

C. Andrew Boswell | doi.page

0 works0 citations0 h-index

C. Andrew Boswell

Gene Therapy Laboratory(FR)Institute for Clinical Pharmacodynamics (United States)(US)PharmacoGenetics (China)(CN)

Publications by Year

Research Areas

Monoclonal and Polyclonal Antibodies Research, HER2/EGFR in Cancer Research, Radiopharmaceutical Chemistry and Applications, Glycosylation and Glycoproteins Research, Protein purification and stability

Most-Cited Works

→ Comparative in Vivo Stability of Copper-64-Labeled Cross-Bridged and Conventional Tetraazamacrocyclic Complexes(2004)476 cited
→ Effects of Charge on Antibody Tissue Distribution and Pharmacokinetics(2010)397 cited
→ Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants(2014)339 cited
→ Development of radioimmunotherapeutic and diagnostic antibodies: an inside-out view(2007)233 cited
→ Radiolabeling and In Vivo Behavior of Copper-64-Labeled Cross-Bridged Cyclam Ligands(2001)225 cited
→ Impact of Drug Conjugation on Pharmacokinetics and Tissue Distribution of Anti-STEAP1 Antibody–Drug Conjugates in Rats(2011)202 cited

→ Preclinical pharmacokinetics, pharmacodynamics, tissue distribution, and tumor penetration of anti-PD-L1 monoclonal antibody, an immune checkpoint inhibitor(2016)

197 cited

→ Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies(2015)194 cited

→ Kinetic Inertness and Electrochemical Behavior of Copper(II) Tetraazamacrocyclic Complexes: Possible Implications for in Vivo Stability(2005)171 cited

→ Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model(2018)151 cited